- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Japanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
5
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
5 companies
Mochida Pharmaceutical
Market Cap: JP¥117.2b
Manufactures and sells pharmaceuticals and healthcare products in Japan.
4534
JP¥3,305.00
7D
-5.4%
1Y
-8.1%
KYORIN Pharmaceutical
Market Cap: JP¥85.3b
Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.
4569
JP¥1,485.00
7D
-2.0%
1Y
0.3%
Heartseed
Market Cap: JP¥41.5b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥1,823.00
7D
5.7%
1Y
19.9%
Shin Nippon Biomedical Laboratories
Market Cap: JP¥75.5b
A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.
2395
JP¥1,813.00
7D
-0.5%
1Y
14.7%
Hisamitsu Pharmaceutical
Market Cap: JP¥292.0b
Manufactures and sells pharmaceuticals in Japan.
4530
JP¥4,153.00
7D
-3.1%
1Y
-2.1%